OBJECTIVE: To determine whether group A streptococcal infection and poststreptococcal sequelae are still a significant health issue for Aboriginal communities. DESIGN: A cross-sectional survey of streptococcal carriage, infection and antibody levels. SETTING: A north Queensland Aboriginal community. PARTICIPANTS: One hundred and twenty preschool and school-aged children (2 to 12 years of age) living in the Lockhart River Community on Cape York Peninsula. RESULTS: Pyoderma was present in 43% of the children and in 76% of these culture of skin lesions grew group A streptococci. Group A streptococci also grew from 13% of throat swabs, making a total of 36% of children culture positive. Anti-streptolysin O and anti-DNAase B levels were remarkably high and increased with age. CONCLUSIONS: The evidence presented confirms a high level of group A streptococcal carriage and infection in children of the Lockhart River Community. Further investigation of this problem is warranted in other Aboriginal communities with a view to instituting appropriate control programs.
OBJECTIVE: To determine whether group A streptococcal infection and poststreptococcal sequelae are still a significant health issue for Aboriginal communities. DESIGN: A cross-sectional survey of streptococcal carriage, infection and antibody levels. SETTING: A north Queensland Aboriginal community. PARTICIPANTS: One hundred and twenty preschool and school-aged children (2 to 12 years of age) living in the Lockhart River Community on Cape York Peninsula. RESULTS: Pyoderma was present in 43% of the children and in 76% of these culture of skin lesions grew group A streptococci. Group A streptococci also grew from 13% of throat swabs, making a total of 36% of children culture positive. Anti-streptolysin O and anti-DNAase B levels were remarkably high and increased with age. CONCLUSIONS: The evidence presented confirms a high level of group A streptococcal carriage and infection in children of the Lockhart River Community. Further investigation of this problem is warranted in other Aboriginal communities with a view to instituting appropriate control programs.
Authors: P C Valery; M Wenitong; V Clements; M Sheel; D McMillan; J Stirling; K S Sriprakash; M Batzloff; R Vohra; J S McCarthy Journal: Epidemiol Infect Date: 2007-10-24 Impact factor: 2.451
Authors: Andrew C Steer; Suzanna Vidmar; Roselyn Ritika; Joseph Kado; Michael Batzloff; Adam W J Jenney; John B Carlin; Jonathan R Carapetis Journal: Clin Vaccine Immunol Date: 2008-12-03
Authors: Ross S Bailie; Matthew R Stevens; Elizabeth McDonald; Stephen Halpin; David Brewster; Gary Robinson; Stephen Guthridge Journal: BMC Public Health Date: 2005-12-08 Impact factor: 3.295
Authors: Asha C Bowen; Antoine Mahé; Roderick J Hay; Ross M Andrews; Andrew C Steer; Steven Y C Tong; Jonathan R Carapetis Journal: PLoS One Date: 2015-08-28 Impact factor: 3.240
Authors: Stacey O'Shea; Carmel M Hawley; Stephen P McDonald; Fiona G Brown; Johan B Rosman; Kathryn J Wiggins; Kym M Bannister; David W Johnson Journal: BMC Nephrol Date: 2009-07-26 Impact factor: 2.388